(Q33834897)

29 July 2017

1 reference

title

ADEM: literature review and case report of acute psychosis presentation (English)

1 reference

29 July 2017

1 reference

Nasr JT

1

1 reference

PubMed ID

10669199

29 July 2017

Andriola MR

series ordinal

2

1 reference

PubMed ID

10669199

29 July 2017

Coyle PK

series ordinal

3

1 reference

29 July 2017

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

22

1 reference

29 July 2017

1

1 reference

29 July 2017

8-18

1 reference

The pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Acute disseminated encephalomyelitis after accidental injection of a hog vaccine: successful treatment with plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Acute viral encephalitis: its diagnosis and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Measles Encephalomyelitis — Clinical and Immunologic Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Measles: summary of worldwide impact

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Neurological complications due to beta-propiolactone (BPL)-inactivated antirabies vaccination. Clinical, electrophysiological and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Cranial MRI in acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Subacute sclerosing panencephalitis presenting as acute disseminated encephalomyelitis: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Inflammatory demyelinating polyradiculitis in a patient with acute disseminated encephalomyelitis (ADEM).

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Guillain-Barré syndrome (GBS) with bilateral optic neuritis and central white matter disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Acute, severe, central and peripheral nervous system combined demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Acute severe combined demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Acute Disseminated Encephalomyelitis Presenting as an Acute Psychotic State

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Acute disseminated encephalomyelitis in middle-aged or elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Acquired Reversible Autistic Syndrome in Acute Encephalopathic Illness in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Subtle encephalomyelitis in children: a variant of acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Multiple sclerosis presenting with acute remitting psychiatric symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

The neuropsychiatry of adult-onset adrenoleukodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Subacute sclerosing panencephalitis presenting as schizophreniform psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Immunocytochemical study of Myelin-associated Glycoprotein (MAG) and Basic Protein (BP) in acute Experimental Allergic Encephalomyelitis (EAE)

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Computed tomography in acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Viral infections of the CNS in children: imaging features

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

MRI in children with postinfectious disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Acute disseminated encephalomyelitis: the importance of early magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

MR imaging of multiple sclerosis: comparison with clinical and CT examinations in 74 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Suspected acute encephalopathy with symmetrical abnormal signal areas in the basal ganglia, thalamus, midbrain and pons diagnosed by magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Serial magnetic resonance imaging in children with postinfectious encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Neurological complications of swine influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Relapsing central and peripheral demyelinating diseases. Unusual pathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Acute disseminated encephalomyelitis presenting as a solitary brainstem mass

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Destructive lesions in demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Neurological picture. Acute disseminated encephalomyelitis presenting as multiple cystic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Multiphasic disseminated encephalomyelitis presenting as alternating hemiplegia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Recurrent encephalomyelitis in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Grand rounds--Hammersmith Hospitals. Distinguishing acute disseminated encephalomyelitis from multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Heat shock protein immunoreactivity in CSF: correlation with oligoclonal banding and demyelinating disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Corticotropin is superior to corticosteroids in the treatment of MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Acute disseminated encephalitis. Some therapeutic and diagnostic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Acute disseminated encephalomyelitis and acute disseminated sclerosis; results of treatment with A.C.T.H.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Steroid-responsive encephalomyelitis in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Early high-dose intravenous methylprednisolone in acute disseminated encephalomyelitis: a successful recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Early high-dose methylprednisolone in acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Steroid-dependent postvaricella encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Corticosteroid treatment for measles encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

CORTICOSTEROID TREATMENT FOR ACUTE MENINGOENCEPHALITIS: A RETROSPECTIVE STUDY OF 346 CASES.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Plasmapheresis in fulminant acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Acute hemorrhagic leukoencephalitis. A successful recovery.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Role of plasmapheresis in acute disseminated (postinfectious) encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Plasma exchange in acute post-infectious demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Neurological deficit associated with Mycoplasma pneumoniae reversed by plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Acute disseminated encephalomyelitis: response to intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Effect of a synthetic polypeptide (COP 1) on patients with multiple sclerosis and with acute disseminated encephalomeylitis. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Poly ICLC in the Treatment of Postinfectious Demyelinating Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Cyclosporine in neurological autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Involvement of cytokines in N-methyl-N'-nitro-N-nitrosoguanidine-induced plasminogen activator activity in acute disseminated encephalomyelitis and multiple sclerosis lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Measles encephalomyelitis: Lack of evidence of viral invasion of the central nervous system and quantitative study of the nature of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

THE RAPID PRODUCTION OF ACUTE DISSEMINATED ENCEPHALOMYELITIS IN RHESUS MONKEYS BY INJECTION OF HETEROLOGOUS AND HOMOLOGOUS BRAIN TISSUE WITH ADJUVANTS.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Experimental Allergic Encephalomyelitis and Autoimmune Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Neurovascular fibrinolytic activity in normal Lewis rats and rats with cell-transferred experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Studies on the pathogenesis of multiple sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Gamma-interferon induction in patients with chronic progressive MS

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900116-2

7 January 2021

10.1016/S0887-8994(99)00116-2

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10669199